Related Experiment Videos
Transmitral flow changes during dipyridamole-induced ischemia. A Doppler-echocardiographic study
F Lattanzi1, E Picano, M Masini
1Istituto di Fisiologia Clinica del CNR, Università di Pisa, Italy.
Chest
|May 1, 1989
Summary
Dipyridamole echocardiography tests reveal that myocardial ischemia alters left ventricular (LV) diastolic compliance. This ischemia increases the atrial contribution to LV filling, suggesting impaired LV relaxation.
Area of Science:
- Cardiology
- Echocardiography
- Physiology
Background:
- Myocardial ischemia impacts left ventricular (LV) diastolic compliance.
- Doppler echocardiography detects abnormal mitral inflow patterns in ischemia.
- Regional myocardial systolic function is crucial in assessing ischemic heart disease.
Purpose of the Study:
- To investigate the relationship between Doppler echocardiography findings and regional myocardial systolic function during dipyridamole infusion.
- To evaluate transmitral flow changes during a high-dose dipyridamole echocardiography test (DET).
Main Methods:
- Utilized pulsed Doppler technique to detect transmitral flow changes.
- Administered high-dose dipyridamole (up to 0.84 mg/kg over 10 min) with two-dimensional echo monitoring.
- Classified patients into negative (Group 1) and positive (Group 2) DET response groups based on LV regional asynergy.
Main Results:
- E/A values, representing mitral inflow, differed significantly at peak dipyridamole changes between groups (p < .01).
- Heart rate and R-R intervals remained similar between groups, ruling them out as confounders for Doppler changes.
- Positive DET responses correlated with altered transmitral flow patterns, indicating impaired LV relaxation.
Conclusions:
- Transient myocardial ischemia induced by dipyridamole administration causes significant changes in transmitral flow.
- An increased atrial contribution to LV filling is observed, likely due to acute impairment in LV relaxation.
- Doppler echocardiography effectively detects functional changes associated with myocardial ischemia during dipyridamole stress testing.